Erythropoietin Resistant Anemia (EPO Resistant Anemia)

DBCOND0161719Hemic and Lymphatic Diseases Urogenital Diseases

Erythropoietin Resistant Anemia (EPO Resistant Anemia) is the indication for 1 drug in DrugBank. It is covered by 2 curated, structured indications.

Also known as: Anemia in Chronic Kidney Disease · Anaemia in Chronic Kidney Disease · Chronic Kidney Disease Associated Anemia · Anemia Associated With Chronic Kidney Disease · Anemia in Chronic Kidney Diseases
Classified under: Hemic and Lymphatic Diseases
Urogenital Diseases
Indicated drugs: Vadadustat

Resolves to

Vocabularies

ICD-10D63.1SNOMED CT707323002UMLSC1561828

What you can answer from here — as of October 22, 2026

1Indicated drugWith each drug's targets and mechanism

Listed above

2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

18Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Erythropoietin Resistant Anemia (EPO Resistant Anemia) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account